This discussion predominantly focuses on the impacts of PAR2 in atopic dermatitis, psoriasis, vitiligo, melasma, and other conditions such as rosacea, acne, and dermatomyositis, as summarized in Table 1. This evidence concerns the gene F2RL1 and rosacea.